33161065|t|The dietary fatty acids alpha-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production.
33161065|a|Alzheimer's disease (AD) is a neurodegenerative disorder without a known cure or effective treatment. Research has identified several modifiable risk factors and suggested preventative measures to reduce the risk of developing AD, including alterations in diet. Polyunsaturated fatty acids (PUFAs) have been shown to regulate inflammatory responses in the central nervous system (CNS), the main site of inflammation in AD. In the CNS, microglia are immune cells responsible for the maintenance of homeostasis. However, in AD, microglia can become adversely activated, causing them to release increased levels of cytotoxins and inflammatory mediators, including nitric oxide (NO) and monocyte-chemoattractant protein (MCP)-1. We assessed the effects of two PUFAs, alpha-linolenic acid (ALA) and linoleic acid (LA), on select microglial immune functions, since the effects of these dietary fatty acids on neuroimmune responses are not well characterized. In BV-2 mouse microglia activated with lipopolysaccharide (LPS), exposure to LA reduced NO secretion and inducible nitric oxide synthase (iNOS) levels, whereas exposure to ALA reduced NO without a corresponding reduction of iNOS. Neither ALA nor LA altered MCP-1 levels or cytotoxins released by THP-1 human microglia-like cells stimulated with a combination of LPS and interferon (IFN)-gamma. Specific receptor antagonists were used to demonstrate that the inhibitory effect of LA on NO secretion did not depend on the free fatty acid receptor (FFAR) 1 or FFAR4. Furthermore, gas chromatography with a flame ionization detector (GC-FID) revealed that exposure to LA or ALA did not alter the fatty acid composition of BV-2 microglia. Our data indicate that regulation of select microglial immune functions by ALA and LA could be one of the mechanisms underlying the observed link between certain dietary patterns and AD, such as reduced risk of cognitive decline and dementia associated with the Mediterranean diet.
33161065	12	23	fatty acids	Chemical	MESH:D005227
33161065	24	44	alpha-linolenic acid	Chemical	MESH:D017962
33161065	46	49	ALA	Chemical	MESH:D017962
33161065	55	68	linoleic acid	Chemical	MESH:D019787
33161065	105	117	nitric oxide	Chemical	MESH:D009569
33161065	130	149	Alzheimer's disease	Disease	MESH:D000544
33161065	151	153	AD	Disease	MESH:D000544
33161065	160	186	neurodegenerative disorder	Disease	MESH:D019636
33161065	357	359	AD	Disease	MESH:D000544
33161065	392	419	Polyunsaturated fatty acids	Chemical	MESH:D005231
33161065	421	426	PUFAs	Chemical	MESH:D005231
33161065	456	468	inflammatory	Disease	MESH:D007249
33161065	533	545	inflammation	Disease	MESH:D007249
33161065	549	551	AD	Disease	MESH:D000544
33161065	652	654	AD	Disease	MESH:D000544
33161065	757	769	inflammatory	Disease	MESH:D007249
33161065	791	803	nitric oxide	Chemical	MESH:D009569
33161065	813	853	monocyte-chemoattractant protein (MCP)-1	Gene	6347
33161065	886	891	PUFAs	Chemical	MESH:D005231
33161065	893	913	alpha-linolenic acid	Chemical	MESH:D017962
33161065	915	918	ALA	Chemical	MESH:D017962
33161065	924	937	linoleic acid	Chemical	MESH:D019787
33161065	1018	1029	fatty acids	Chemical	MESH:D005227
33161065	1086	1090	BV-2	CellLine	CVCL:0182
33161065	1091	1096	mouse	Species	10090
33161065	1122	1140	lipopolysaccharide	Chemical	MESH:D008070
33161065	1142	1145	LPS	Chemical	MESH:D008070
33161065	1188	1219	inducible nitric oxide synthase	Gene	18126
33161065	1221	1225	iNOS	Gene	18126
33161065	1255	1258	ALA	Chemical	MESH:D017962
33161065	1307	1311	iNOS	Gene	18126
33161065	1321	1324	ALA	Chemical	MESH:D017962
33161065	1340	1345	MCP-1	Gene	6347
33161065	1379	1384	THP-1	CellLine	CVCL:0006
33161065	1385	1390	human	Species	9606
33161065	1445	1448	LPS	Chemical	MESH:D008070
33161065	1453	1475	interferon (IFN)-gamma	Gene	3458
33161065	1603	1636	free fatty acid receptor (FFAR) 1	Gene	2864
33161065	1640	1645	FFAR4	Gene	338557
33161065	1753	1756	ALA	Chemical	MESH:D017962
33161065	1775	1785	fatty acid	Chemical	MESH:D005227
33161065	1801	1805	BV-2	CellLine	CVCL:0182
33161065	1892	1895	ALA	Chemical	MESH:D017962
33161065	2000	2002	AD	Disease	MESH:D000544
33161065	2028	2045	cognitive decline	Disease	MESH:D003072
33161065	2050	2058	dementia	Disease	MESH:D003704
33161065	Negative_Correlation	MESH:D009569	MESH:D007249
33161065	Negative_Correlation	MESH:D017962	MESH:D000544
33161065	Negative_Correlation	MESH:D017962	MESH:D003704
33161065	Association	MESH:D007249	6347
33161065	Negative_Correlation	MESH:D009569	MESH:D019787
33161065	Positive_Correlation	MESH:D009569	MESH:D000544
33161065	Negative_Correlation	MESH:D017962	MESH:D003072
33161065	Association	MESH:D000544	6347
33161065	Association	MESH:D005231	MESH:D007249
33161065	Negative_Correlation	MESH:D005227	MESH:D009569
33161065	Negative_Correlation	MESH:D009569	MESH:D017962

